Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Lap IQ Inc
Profile last edited on: 6/6/17      CAGE: 76VZ9      UEI:

Business Identifier: Biodegradable medical device solutions for laparoscopic surgery
Year Founded
2014
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2310 Homestead Road Suite C1 #117
Sunnyvale, CA 94024
   (510) 292-6263
   N/A
   www.lapiq.com
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Lap IQ Inc designs and manufactures biodegradable medical device solutions for laparoscopic surgery. The company's FAStlink device is patent-protected and offers the only non-suture trocoar port closure method being develop for surgeons. The device utilizes biopolymer technology and is aimed at improving cost efficiency in laproscopic surgery.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$395,324
Phase II Dollars
$0
Total Awarded
$395,324

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $245,324
Project Title: Tension-Free Bioabsorbable Scaffold for Pediatric Abdominal Wall Defect Closure
2016 1 NSF $150,000
Project Title: Bioabsorbable Scaffold for Tension-Free Laparoscopic Fascial Defect Closure

Key People / Management

  Michael Fourkas -- Co-Founder and COO

  Michael S Klein -- Founder and CEO

  James Su -- Chief Scientist

  Kenneth Sumner -- FDA Regulatory Consultant

Company News

There are no news available.